全球膿毒症治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計敗血症治療市場將從 2025 年的 72.2 億美元成長到 2034 年的 131.3 億美元，2026 年至 2034 年的複合年成長率為 6.87%。

由於嚴重感染疾病的增加以及人們對膿毒症作為一種危及生命的疾病的認知不斷提高，全球膿毒症治療市場正穩步成長。敗血症是指人體對感染的反應導致廣泛的發炎和器官衰竭。早期診斷和有效治療對於提高存活率至關重要，這也推動了對先進治療方案的需求。

推動市場成長的關鍵因素包括因嚴重感染疾病住院人數的增加，以及醫療專業人員對早期發現敗血症重要性的認知不斷提高。診斷技術的進步和加護病房也促進了市場成長。此外，政府主導的旨在改善感染控制和病人安全的舉措，正在加速推廣有效的敗血症治療通訊協定。

隨著對新治療方法的研究不斷深入以及診斷工具的改進，膿毒症治療市場預計將持續成長。製藥公司正致力於開發標靶治療和免疫調節療法，以改善患者預後。由於早期療育和重症監護在醫療保健系統中仍然至關重要，因此對有效膿毒症治療方法的需求預計將會增加。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球膿毒症治療市場：按類型分類

• 市場分析、洞察與預測
• 嚴重敗血症
• 敗血性休克
• 需要血液淨化的敗血症

第5章：全球膿毒症治療市場：依療法分類

• 市場分析、洞察與預測
• 連續性腎臟替代療法（CRRT）
• 間歇性血液透析
• 持續低效每日透析（SLED）
• 其他

第6章 全球膿毒症治療市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專業治療中心
• 其他

第7章 全球敗血症治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Baxter InternationalInc
  • Fresenius Medical Care AG & Co. KGaA
  • Nipro Corporation
  • Asahi Kasei
  • B. Braun Group
  • CytoSorbents Corporation
  • Medtronic Ple
  • Nikkiso CoLtd
  • Medica SPA
  • Toray Industries
  • Merck & Co.Inc

The Sepsis Treatment Market size is expected to reach USD 13.13 Billion in 2034 from USD 7.22 Billion (2025) growing at a CAGR of 6.87% during 2026-2034.

The global sepsis treatment market is growing steadily due to the increasing incidence of severe infections and the rising awareness of sepsis as a life-threatening medical condition. Sepsis occurs when the body's response to infection causes widespread inflammation and organ dysfunction. Early diagnosis and effective treatment are critical to improving survival rates, which is driving the demand for advanced therapeutic solutions.

Key drivers of the market include the growing number of hospital admissions for severe infections and increasing awareness among healthcare professionals about early sepsis detection. Advances in diagnostic technologies and improvements in intensive care unit infrastructure are also supporting market growth. In addition, government initiatives promoting better infection management and patient safety are encouraging the adoption of effective sepsis treatment protocols.

Looking ahead, the sepsis treatment market is expected to expand due to ongoing research into novel therapeutic approaches and improved diagnostic tools. Pharmaceutical companies are focusing on developing targeted therapies and immunomodulatory treatments to improve patient outcomes. As healthcare systems continue to emphasize early intervention and critical care management, demand for effective sepsis treatments is likely to grow.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Severe Sepsis
• Sepsis Shock
• Sepsis in Need of Blood Purification

By Therapy

• Continuous Renal Replacement Therapies (CRRT)
• Intermittent Hemodialysis
• Sustained Low-efficiency Daily Dialysis (SLED)
• Others

By End User

• Hospitals
• Specialty Centers
• Others

COMPANIES PROFILED

• Baxter International, Inc, Fresenius Medical Care AG Co KGaA, Nipro Corporation, Asahi Kasei, B Braun Group, CytoSorbents Corporation, Medtronic ple, Nikkiso Co, Ltd, Medica SPA, Toray Industries, Merck Co, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEPSIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Severe Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sepsis Shock Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sepsis in Need of Blood Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEPSIS TREATMENT MARKET: BY THERAPY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Continuous Renal Replacement Therapies (CRRT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Intermittent Hemodialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sustained Low-efficiency Daily Dialysis (SLED) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEPSIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEPSIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Therapy
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Therapy
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Therapy
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Therapy
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Therapy
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SEPSIS TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Baxter InternationalInc
  • 9.2.2 Fresenius Medical Care AG & Co. KGaA
  • 9.2.3 Nipro Corporation
  • 9.2.4 Asahi Kasei
  • 9.2.5 B. Braun Group
  • 9.2.6 CytoSorbents Corporation
  • 9.2.7 Medtronic Ple
  • 9.2.8 Nikkiso CoLtd
  • 9.2.9 Medica SPA
  • 9.2.10 Toray Industries
  • 9.2.11 Merck & Co.Inc